Loading
Morbid Obesity Requiring Bariatric Surgery / Laparoscopic Sleeve Gastrectomy · Observational Study
ClinicalTrials.gov · August 17, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed observational study registered to examine whether serum apolipoprotein levels predict weight loss outcomes after sleeve gastrectomy in 76 patients with morbid obesity. No results are posted in this registry record, and the observational design without a comparator limits the strength of any future findings to hypothesis-generating or preliminary evidence.
Observational. Morbid Obesity Requiring Bariatric Surgery; age from 18 Years; to 75 Years. Intervention: Sleeve Gastrectomy Patients. n = 76. 1 site: Turkey (Türkiye).
This is a completed observational study registered to examine whether serum apolipoprotein levels predict weight loss outcomes after sleeve gastrectomy in 76 patients with morbid obesity. No results are posted in this registry record, and the observational design without a comparator limits the strength of any future findings to hypothesis-generating or preliminary evidence.
Surrogate outcome (BMI change) rather than clinical hard outcomes (morbidity, mortality, functional improvement).
If results become available, this study may identify apolipoprotein thresholds to predict surgical weight loss success; however, without published outcomes and given the observational design, any findings should be considered exploratory and requiring confirmation in prospective studies before clinical application.
This is a completed observational registry record with no reported results; it describes a planned study examining apolipoprotein as a predictor of weight loss after sleeve gastrectomy, but outcomes are not posted.
As stated by the source record.
Quoted from the source exactly as published.
If results become available, this study may identify apolipoprotein thresholds to predict surgical weight loss success; however, without published outcomes and given the observational design, any findings should be considered exploratory and requiring confirmation in prospective studies before clinical application.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07325916). This is a study registration, not published results. Lead sponsor: Yigit DUZKOYLU. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 76 participants (ACTUAL). Conditions: Morbid Obesity Requiring Bariatric Surgery. Interventions: PROCEDURE: Laparoscopic Sleeve Gastrectomy. Primary outcome measures: Change in body mass index at 8 months , 8 months after surgery. Brief summary: The study looks at whether a specific protein in the blood, called apolipoprotein, can predict how much weight a person might lose after sleeve gastrectomy, a surgery for people with severe obesity. We want to find a specific level of this protein that shows which patients are most likely to lose weight successfully after surgery. By identifying this level, we hope to guide doctors in deciding who should have the surgery and who might do better with non-surgical weight loss methods.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.